Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In May 2020 our researchers initiated a global project to investigate how COVID-19 has affected people with epilepsy, their carers and health care workers.

Close up of hands of two people working at desk with laptops and papers

Working in partnership with local charity SUDEP Action, the Oxford Epilepsy Research Group led by Dr Arjune Sen set out to assess escalation and mitigation of risk. This has now become one of the largest global surveys in epileptology with nearly 4000 responses.

The first paper to come out of this study found that COVID-19 is having far-reaching consequences on people with epilepsy. UK respondents reported changes in seizure frequency, mental health, and sleep. Discussion of risk to people with epilepsy was shown to be infrequent, even before the pandemic. The study showed the importance of delivering optimal care to mitigate risk.

Based on this work, lead author Jennifer Thorpe, who works for SUDEP Action and has an Honorary Agreement with our Department, has just been awarded the International League Against Epilepsy COVID-19 prize for best paper in the European region.

Other papers published to date report on the impact of COVID-19 on epilepsy care, and summarise findings from the Brazilian arm of the study. The researchers are currently working on manuscripts relating to experiences in other countries as well as comparing the differential impact of COVID-19 on people with epilepsy around the world.

Similar stories

Study reveals association between diagnosis of a neuropsychiatric condition and severe outcome from COVID-19 infection, and other severe acute respiratory infections

New research from the University of Oxford has shown an increased risk of severe illness and death from both COVID-19 and other severe respiratory infections, such as influenza and pneumonia, among people with a pre-existing mental health condition.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.

Visit from the Sir Jules Thorn Charitable Trust

Earlier this month, we were delighted to welcome the Director of the Sir Jules Thorn Charitable Trust, Richard Benson, and its Chair of Trustees, Liz Charal.

Oxford receives £122m funding for healthcare research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. Our department will play a major role.